Guidance on the use of rituximab for recurrent or refractory stage III or IV follicular non-Hodgkin's lymphoma

An edition of Guidance on the use of rituximab for recurrent or refractory stage III or IV follicular non-Hodgkin's lymphoma (2002)

Guidance on the use of rituximab for recurrent or refractory stage III or IV follicular non-Hodgkin's lymphoma

By National Institute for Clinical Excellence.

0 (0 Ratings)

0 Want to read0 Currently reading0 Have read

Publish Date

2002

Publisher

NICE

Language

eng

Pages

RelatedBooks